SLC5A2 and heart failure: Several larger RCTs evaluating safety and efficacy of SGLT2 inhibitors in acute heart failure are currently ongoing: DICTATE-AHF [73•], DAPA ACT HF-TIMI 68 [74], Dapagliflozin Heart Failure Readmissions [74], and EMPULSE [75].